{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:51:38Z","timestamp":1781653898637,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Krebsforschungszentrum (DKFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Eligibility criteria for lung cancer (LC) screening aim to identify long-term smokers who have exceeded a minimum-risk threshold of having LC, while still having sufficiently long remaining life expectancy. For individuals who have once met eligibility criteria (i.e., reached sufficiently high LC risk), a question is whether longer-term smoking cessation and corresponding improvement in other-cause mortality risk could justify a higher maximum screening age for former smokers than for continuing smokers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed time-varying Cox models in the EPIC-Heidelberg cohort (N\u2009=\u200924,715), using 3-yearly questionnaire data collected between 1994 and 2014 to estimate hazard ratios (HRs) and incidence rates for death by LC or other causes, in relation to age-specific smoking status and eligibility by German LC screening criteria (LCSC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Depending on age, models showed up to 3-fold higher risk of other-cause mortality for recent and LCSC-eligible smokers, relative to never smokers. Among former smokers, those who quit before age 30 or 40 showed no significant difference in other-cause mortality compared with never-smokers, in men and women, respectively. However, at higher quitting ages HRs increased up to about 1.9 for men who stopped at age \u226560, or 1.5 in women who stopped at age 50-&lt;60. Also, depending on age, former smokers who had once met the LCSC, but then quit for &gt;10 years (thereby losing formal screening eligibility), showed HRs of about 1.5\u20133.0 for other-cause mortality in men and 1.3\u20131.9 in women. In both sexes, the absolute incidence rate for other-cause mortality amongst past-eligible smokers age 75-&lt;80 was similar to that for current-eligible smokers of the younger, 70-&lt;75-year age group. For LC, both current and former smoking were associated with persistently increased HRs, even after long-term cessation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For smokers who once met LCSC, but then quit for &gt;10 years the risk of other-causes mortality remains elevated, but less so than for continuing smokers, which may argue for a moderate extension of the maximum age limit for LC screening. Larger studies will be needed to obtain more precise risk estimates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-04891-z","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:47:02Z","timestamp":1777376822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Smoking history, eligibility for lung cancer screening and risk of death by lung cancer or other causes -- a longitudinal, time-variable analysis of the EPIC-Heidelberg cohort"],"prefix":"10.1186","volume":"24","author":[{"given":"Yue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srimanti","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmita","family":"Bajracharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cort\u00e8s-Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e Turzanski","family":"Fortner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Katzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Kaaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"6","key":"4891_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/jnci\/85.6.457","volume":"85","author":"MT Halpern","year":"1993","unstructured":"Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst. 1993;85(6):457\u201364.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"4891_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0969141315579119","volume":"22","author":"PF Pinsky","year":"2015","unstructured":"Pinsky PF, Zhu CS, Kramer BS. Lung cancer risk by years since quitting in 30+ pack year smokers. J Med Screen. 2015;22(3):151\u20137.","journal-title":"J Med Screen"},{"issue":"11","key":"4891_CR3","first-page":"1201","volume":"110","author":"HA Tindle","year":"2018","unstructured":"Tindle HA, Stevenson Duncan M, Greevy RA, Vasan RS, Kundu S, Massion PP, et al. Lifetime smoking history and risk of lung cancer: results from the Framingham Heart study. J Natl Cancer Inst. 2018;110(11):1201\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"4891_CR4","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1001\/jamaoncol.2022.2952","volume":"8","author":"C Faselis","year":"2022","unstructured":"Faselis C, Nations JA, Morgan CJ, Antevil J, Roseman JM, Zhang S, et al. Assessment of lung cancer risk among smokers for whom annual screening is not recommended. JAMA Oncol. 2022;8(10):1428\u201337.","journal-title":"JAMA Oncol"},{"issue":"5","key":"4891_CR5","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s13524-018-0707-2","volume":"55","author":"JT Lariscy","year":"2018","unstructured":"Lariscy JT, Hummer RA, Rogers RG. Cigarette smoking and all-cause and cause-specific adult mortality in the United States. Demography. 2018;55(5):1855\u201385.","journal-title":"Demography"},{"issue":"9","key":"4891_CR6","doi-asserted-by":"publisher","first-page":"e691","DOI":"10.1016\/S2468-2667(23)00131-7","volume":"8","author":"AF Fares","year":"2023","unstructured":"Fares AF, Li Y, Jiang M, Brown MC, Lam ACL, Aggarwal R, et al. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. Lancet Public Health. 2023;8(9):e691\u2013e700.","journal-title":"Lancet Public Health"},{"issue":"4","key":"4891_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMsa1211128","volume":"368","author":"P Jha","year":"2013","unstructured":"Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341\u201350.","journal-title":"N Engl J Med"},{"issue":"9861","key":"4891_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0140-6736(12)61720-6","volume":"381","author":"K Pirie","year":"2013","unstructured":"Pirie K, Peto R, Reeves GK, Green J, Beral V, Million Women Study C. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381(9861):133\u201341.","journal-title":"Lancet"},{"issue":"6","key":"4891_CR9","doi-asserted-by":"publisher","first-page":"e2317351","DOI":"10.1001\/jamanetworkopen.2023.17351","volume":"6","author":"S Woloshin","year":"2023","unstructured":"Woloshin S, Landsman V, Miller DG, Byrne J, Graubard BI, Feuer EJ. Updating the know your chances website to include smoking status as a risk factor for mortality estimates. JAMA Netw Open. 2023;6(6):e2317351.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"4891_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMsa1407211","volume":"372","author":"BD Carter","year":"2015","unstructured":"Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, et al. Smoking and mortality-beyond established causes. N Engl J Med. 2015;372(7):631\u201340.","journal-title":"N Engl J Med"},{"issue":"12","key":"4891_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/jnci\/djn124","volume":"100","author":"S Woloshin","year":"2008","unstructured":"Woloshin S, Schwartz LM, Welch HG. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst. 2008;100(12):845\u201353.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"4891_CR12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.2021.1799","volume":"325","author":"J Jin","year":"2021","unstructured":"Jin J. Screening for lung cancer. JAMA. 2021;325(10):1016.","journal-title":"JAMA"},{"issue":"1","key":"4891_CR13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/a-2175-4580","volume":"78","author":"TG Blum","year":"2024","unstructured":"Blum TG, Vogel-Claussen J, Andreas S, Bauer TT, Barkhausen J, Harth V, et al. [Statement paper on the implementation of a national organized program in Germany for the early detection of lung cancer in risk populations using low-dose CT screening including management of screening findings]. Pneumologie. 2024;78(1):15\u201334.","journal-title":"Pneumologie"},{"issue":"6","key":"4891_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1503\/cmaj.151421","volume":"188","author":"Canadian Task Force on Preventive Health C","year":"2016","unstructured":"Canadian Task Force on Preventive Health C. Recommendations on screening for lung cancer. CMAJ. 2016;188(6):425\u201332.","journal-title":"CMAJ"},{"key":"4891_CR15","unstructured":"NHS. Standard protocol and quality assurance standards for the lung cancer screening programme. NHS England website; 2019 [Available from: https:\/\/www.england.nhs.uk\/publication\/targeted-screening-for-lung-cancer\/"},{"key":"4891_CR16","unstructured":"Federal Ministry for the Environment CA, Nature conservation and nuclear safety lung cancer screening ordinance: lung cancer screening using low-dose computed tomography for population groups at risk. 2025 [Available from: https:\/\/www.bundesumweltministerium.de\/en\/law\/lung-cancer-screening-ordinance"},{"issue":"2","key":"4891_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/cncr.34758","volume":"130","author":"R Landy","year":"2024","unstructured":"Landy R, Cheung LC, Young CD, Chaturvedi AK, Katki HA. Absolute lung cancer risk increases among individuals with >15 quit-years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines. Cancer. 2024;130(2):201\u201315.","journal-title":"Cancer"},{"issue":"2","key":"4891_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/cncr.34999","volume":"130","author":"MC Tammemagi","year":"2024","unstructured":"Tammemagi MC. Time to quit using quit time as a lung cancer screening eligibility criterion. Cancer. 2024;130(2):182\u20135.","journal-title":"Cancer"},{"issue":"2","key":"4891_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/cncr.34925","volume":"130","author":"R Meza","year":"2024","unstructured":"Meza R, Cao P, de Nijs K, Jeon J, Smith RA, Ten Haaf K, et al. Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold: a simulation modeling study. Cancer. 2024;130(2):244\u201355.","journal-title":"Cancer"},{"issue":"4","key":"4891_CR20","doi-asserted-by":"publisher","first-page":"e1002277","DOI":"10.1371\/journal.pmed.1002277","volume":"14","author":"K Ten Haaf","year":"2017","unstructured":"Ten Haaf K, Jeon J, Tammemagi MC, Han SS, Kong CY, Plevritis SK, et al. Risk prediction models for selection of lung cancer screening candidates: a Retrospective Validation study. PLoS Med. 2017;14(4):e1002277.","journal-title":"PLoS Med"},{"issue":"6","key":"4891_CR21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.2105\/AJPH.92.6.990","volume":"92","author":"DH Taylor Jr.","year":"2002","unstructured":"Taylor DH Jr., Hasselblad V, Henley SJ, Thun MJ, Sloan FA. Benefits of smoking cessation for longevity. Am J Public Health. 2002;92(6):990\u20136.","journal-title":"Am J Public Health"},{"issue":"10","key":"4891_CR22","doi-asserted-by":"publisher","first-page":"e2231480","DOI":"10.1001\/jamanetworkopen.2022.31480","volume":"5","author":"B Thomson","year":"2022","unstructured":"Thomson B, Emberson J, Lacey B, Lewington S, Peto R, Jemal A, et al. Association between smoking, smoking cessation, and mortality by race, ethnicity, and sex among US adults. JAMA Netw Open. 2022;5(10):e2231480.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4891_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000012787","volume":"43","author":"H Boeing","year":"1999","unstructured":"Boeing H, Korfmann A, Bergmann MM. Recruitment procedures of EPIC-Germany. European investigation into cancer and nutrition. Ann Nutr Metab. 1999;43(4):205\u201315.","journal-title":"Ann Nutr Metab"},{"issue":"6B","key":"4891_CR24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1079\/PHN2002394","volume":"5","author":"E Riboli","year":"2002","unstructured":"Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113\u201324.","journal-title":"Public Health Nutr"},{"issue":"10","key":"4891_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10654-020-00657-w","volume":"35","author":"A Husing","year":"2020","unstructured":"Husing A, Kaaks R. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data. Eur J Epidemiol. 2020;35(10):899\u2013912.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"4891_CR26","first-page":"6","volume":"7","author":"A Starker","year":"2022","unstructured":"Starker A, Kuhnert R, Hoebel J, Richter A. Smoking behaviour and passive smoke exposure of adults - Results from GEDA 2019\/2020-EHIS. J Health Monit. 2022;7(3):6\u201320.","journal-title":"J Health Monit"},{"issue":"1","key":"4891_CR27","first-page":"e13038","volume":"10","author":"A Starker","year":"2025","unstructured":"Starker A, Schienkiewitz A, Damerow S, Kuhnert R. Prevalence of obesity and smoking among adults in Germany - trends from 2003 to 2023. J Health Monit. 2025;10(1):e13038.","journal-title":"J Health Monit"},{"issue":"2","key":"4891_CR28","first-page":"57","volume":"2","author":"J Zeiher","year":"2017","unstructured":"Zeiher J, Kuntz B, Lange C. Smoking among adults in Germany. J Health Monit. 2017;2(2):57\u201363.","journal-title":"J Health Monit"},{"key":"4891_CR29","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s00103-018-2818-8","volume":"61","author":"B Kuntz","year":"2018","unstructured":"Kuntz B, Kroll LE, Hoebel J, Schumann M, Zeiher J, Starker A, et al. Zeitliche Entwicklung berufsgruppenspezifischer Unterschiede im Rauchverhalten von erwerbst\u00e4tigen M\u00e4nnern und Frauen in Deutschland. Bundesgesundheitsbl. 2018;61:1388\u201398.","journal-title":"Bundesgesundheitsbl"},{"issue":"1","key":"4891_CR30","first-page":"84","volume":"74","author":"KK Kondo","year":"2024","unstructured":"Kondo KK, Rahman B, Ayers CK, Relevo R, Griffin JC, Halpern MT. Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack-year history: a systematic review. CA Cancer J Clin. 2024;74(1):84\u2013114.","journal-title":"CA Cancer J Clin"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04891-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04891-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04891-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:52:54Z","timestamp":1781650374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04891-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4891"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04891-z","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants at baseline, and the EPIC-Heidelberg study was approved by the Medical Ethics Committee of Heidelberg University (reference number 13\/94).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"274"}}